Benchmark reiterates Buy on Trade Desk stock, cites oversold valuation By Investing.com

The Trade Desk remains under pressure despite Benchmark reiterating a Buy rating and $40 price target, as the stock trades at $24.12, down 57% over the past year and 49% over six months. The article highlights cautious demand, multiple downward earnings revisions, and concerns about AI-driven competition and internal audit issues at Publicis that could affect first-quarter estimates. Leadership departures add to the uncertainty, even as Benchmark argues the stock is oversold at 7.8x EV/NTM EBITDA with about 12% adjusted EBITDA growth expected through 2027.

Analysis

The key read-through is that the market is separating names with durable monetization leverage from names where AI is being interpreted as an ongoing cost center. TTD is now being treated as a governance/credibility story rather than a pure growth asset: when a platform trades at depressed multiples while estimates keep getting cut, the stock can stay cheap for months until management proves margin stabilization or demand acceleration. That creates a regime where any incremental disappointment is punished more than the absolute fundamental miss would suggest.

The second-order effect is on the broader ad-tech cohort and on large agency-distribution relationships. If major agencies are publicly flagging process or audit issues, advertisers may slow budget commitments into programmatic channels, temporarily benefiting “safer” walled gardens and first-party ecosystems over independent demand-side platforms. At the same time, competitors with clearer measurement and stronger direct relationships can pick up share even without industry-wide ad growth, which means TTD’s problem is partly share loss, not just cyclicality.

The contrarian view is that the selloff may be over-rotating on near-term estimate cuts while underpricing the probability that AI spend eventually improves product differentiation and pricing power. At roughly this valuation band, the stock does not need a full re-rating to work; it only needs the market to stop assuming another down-leg in consensus. The catalyst window is likely 1-2 quarters: if management can avoid another margin reset and show even modest reacceleration in customer spend, the stock can recover sharply because positioning is already impaired. If not, the downside extends over 6-12 months as buy-side models continue to compress terminal growth assumptions.

Key Decisions for Investors

• Short TTD into any relief rally over the next 2-6 weeks; use the move to reduce timing risk because the stock remains vulnerable to estimate revisions and governance headlines. Risk/reward favors a tactical short rather than a core bearish position given valuation support.
• Pair trade: long META / short TTD for 1-2 quarters. Thesis: large first-party platforms should retain ad spend if agencies become more cautious on independent DSPs; this isolates execution risk at TTD while keeping exposure to ad market resilience.
• If forced to express a bullish contrarian view, buy TTD call spreads 3-6 months out only after a quarter with no further EBITDA/margin cut. The trade needs a credibility reset, not just a cheap multiple.
• For broader ad-tech exposure, rotate toward names with clearer operating leverage and less platform-governance overhang; avoid sizing up in independent DSPs until there is evidence of stabilizing revision breadth.